UNIGENE LABORATORIES INC Research and Development Expense
UNIGENE LABORATORIES INC reported Research and Development Expense of $850.52 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2013-05-14
- UNIGENE LABORATORIES INC research and development expense for the quarter ending 2013-03-31 was $850.52K, a 32.43% decline year-over-year.
- UNIGENE LABORATORIES INC research and development expense for the quarter ending 2012-12-31 was $1.52M, a 32.56% decline year-over-year.
- UNIGENE LABORATORIES INC research and development expense for the quarter ending 2012-09-30 was $1.15M, a 48.58% decline year-over-year.
- UNIGENE LABORATORIES INC research and development expense for the quarter ending 2012-06-30 was $1.38M, a 34.26% decline year-over-year.
- UNIGENE LABORATORIES INC research and development expense for fiscal 2012 was $5.31M, a 41.09% decline from fiscal 2011.
- UNIGENE LABORATORIES INC research and development expense for fiscal 2011 was $9.02M, a 40.26% increase from fiscal 2010.
- UNIGENE LABORATORIES INC research and development expense for fiscal 2010 was $6.43M, a 47.95% decline from fiscal 2009.
- UNIGENE LABORATORIES INC research and development expense for fiscal 2009 was $12.35M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2013-03-31 | $850.52K 10-Q · filed 2013-05-14 | $2.37M derived: sum of 2 quarters · filed 2013-05-14 | $3.52M derived: sum of 3 quarters · filed 2013-05-14 | $4.90M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $2.67M derived: sum of 2 quarters · filed 2013-03-15 | $4.05M derived: sum of 3 quarters · filed 2013-03-15 | $5.31M 10-K · filed 2013-03-15 |
| 2012-09-30 | $1.15M 10-Q · filed 2013-01-31 | $2.53M derived: sum of 2 quarters · filed 2013-01-31 | $3.79M 10-Q · filed 2013-01-31 | $6.04M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-06-30 | $1.38M 10-Q/A · filed 2013-01-31 | $2.64M 10-Q/A · filed 2013-01-31 | $4.89M derived: sum of 3 quarters · filed 2013-05-14 | $7.13M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-03-31 | $1.26M 10-Q · filed 2013-05-14 | $3.51M derived: sum of 2 quarters · filed 2013-05-14 | $5.76M derived: sum of 3 quarters · filed 2013-05-14 | $7.85M derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $4.50M derived: sum of 2 quarters · filed 2013-03-15 | $6.59M derived: sum of 3 quarters · filed 2013-03-15 | $9.02M 10-K · filed 2013-03-15 |
| 2011-09-30 | $2.25M 10-Q · filed 2013-01-31 | $4.34M derived: sum of 2 quarters · filed 2013-01-31 | $6.76M 10-Q · filed 2013-01-31 | $8.24M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $2.10M 10-Q/A · filed 2013-01-31 | $4.52M 10-Q/A · filed 2013-01-31 | $5.99M derived: sum of 3 quarters · filed 2013-03-15 | $7.58M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $2.42M 10-Q/A · filed 2013-01-31 | $3.89M derived: sum of 2 quarters · filed 2013-03-15 | $5.48M derived: sum of 3 quarters · filed 2013-03-15 | $7.12M derived: sum of 4 quarters · filed 2013-03-15 |
| 2010-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $3.06M derived: sum of 2 quarters · filed 2013-03-15 | $4.70M derived: sum of 3 quarters · filed 2013-03-15 | $6.43M 10-K · filed 2013-03-15 |
| 2010-09-30 | $1.59M 10-Q · filed 2011-11-09 | $3.22M derived: sum of 2 quarters · filed 2011-11-09 | $4.95M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $1.63M 10-Q · filed 2011-08-09 | $3.37M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $12.35M 10-K/A · filed 2013-01-31 |